Ukuqonda ivolumu yokujiya kwegazi: ububanzi obujwayelekile kanye nokubaluleka kwempilo

Emkhakheni wezempilo yezokwelapha, umsebenzi wokujiya kwegazi uyisixhumanisi esibalulekile ekugcineni isimo somzimba womuntu esijwayelekile. Umthamo wokujiya kwegazi, ovame ukulinganiswa ngezinkomba ezihlobene nokujiya kwegazi, udlala indima ebalulekile ekwahluleleni isimo sempilo yomzimba womuntu. Ngakho-ke, lingakanani inani elijwayelekile lokujiya kwegazi? Le nkinga ihlobene nokuxilongwa nokwelashwa kweziguli eziningi, futhi idonsele ukunaka okukhulu kochwepheshe bezokwelapha kanye nomphakathi.

Ngokuvamile, izinkomba zokuhlola umsebenzi wokuqina kwemithambo ezisetshenziswa kakhulu emitholampilo zifaka phakathi isikhathi se-prothrombin (PT), isikhathi se-activated partial thromboplastin (APTT), isikhathi se-thrombin (TT) kanye ne-fibrinogen (FIB).
Ububanzi obujwayelekile balezi zinkomba yilobu:
Isikhathi se-Prothrombin (PT) ngokuvamile siphakathi kwemizuzwana eyi-10 neyi-14, futhi sibalulekile ngokwezokwelapha uma sidlula ukulawula okuvamile ngemizuzwana engaphezu kwemi-3;
Isikhathi esijwayelekile sesikhathi se-activated partial thromboplastin (APTT) singamasekhondi angu-25 kuya kwangu-37, futhi uma sidlula isikhathi esijwayelekile sokulawula ngemizuzwana engaphezu kweyi-10, kufanele sithathwe ngokungathi sína;
Isikhathi esijwayelekile se-thrombin (TT) singamasekhondi angu-12 kuya kwangu-16, futhi ukudlula ukulawula okuvamile ngemizuzwana engaphezu kwemi-3 kubonisa ukuthi kungase kube nokuphazamiseka;
Okuqukethwe okuvamile kwe-fibrinogen (FIB) kuphakathi kuka-2 no-4g/L.

Kodwa-ke, kufanele kuqashelwe ukuthi ngenxa yokwehluka kwezindlela zokuhlola, ama-reagent kanye nezinsimbi ezisetshenziswa yizibhedlela ezahlukene, ububanzi obujwayelekile bamanani okujiya bungase buhluke kancane. Ngakho-ke, ububanzi obujwayelekile bokubhekisela kufanele busekelwe efomini lombiko wesibhedlela lapho isiguli selashwa khona.

Umthamo wokujiya okungajwayelekile uvame ukuhlotshaniswa kakhulu nezifo ezahlukahlukene. Uma umthamo wokujiya uphezulu kakhulu, kungase kube ngenxa yezifo ezifana ne-thrombocytosis, i-polycythemia vera, kanye ne-dispersed intravascular coagulation, okwandisa ukujiya kwegazi futhi ngaleyo ndlela kwandise ingozi ye-thrombosis. Ngaphezu kwalokho, eminye imithi efana ne-anticoagulants (i-heparin, i-warfarin), imithi ye-antiplatelet (i-aspirin, i-clopidogrel), imithi ye-chemotherapy, kanye nokwelashwa okufana ne-hemodialysis kanye ne-extracorporeal membrane oxygenation (ECMO) kungathinta nomsebenzi wokujiya kwegazi, okuholela ekujiya kwegazi ngokweqile. Ngokuphambene nalokho, umsebenzi wokujiya kwegazi ongajwayelekile ungabangelwa ukuntuleka kwe-heitary coagulation factor, ukuntuleka kwe-vitamin K, i-thrombocytopenia, ukusetshenziswa ngokweqile kwe-anticoagulants, kanye nezifo zokusebenzisa i-coagulation factor. Lezi zimo zingaholela ezinkingeni zokujiya kwegazi futhi zivame ukopha.

Kumphakathi, kubaluleke kakhulu ukuqonda ububanzi obujwayelekile bomthamo wokujiya kanye nolwazi olufanele ngomsebenzi wokujiya ongavamile. Uma kutholakala umthamo wokujiya ongavamile ngesikhathi sokuhlolwa ngokomzimba noma ukwelashwa, udokotela kufanele abonisane naye ngesikhathi ukuze acacise imbangela futhi athathe izinyathelo ezifanele zokwelapha. Ngesikhathi esifanayo, ukuhlolwa ngokomzimba njalo kanye nokugcina indlela yokuphila enempilo nakho kuhle ekugcineni umsebenzi wokujiya ojwayelekile.

I-Beijing Succeeder Technology Inc. (ikhodi yesitoko: 688338) ibilokhu ihileleke kakhulu emkhakheni wokuxilongwa kokuqina kwegazi selokhu yasungulwa ngo-2003, futhi izibophezele ekubeni ngumholi kulo mkhakha. Indlunkulu yayo eBeijing, inethimba eliqinile le-R&D, lokukhiqiza kanye nelokuthengisa, eligxile ekusungulweni nasekusetshenzisweni kobuchwepheshe bokuxilonga i-thrombosis kanye ne-hemostasis.

Ngenxa yamandla ayo obuchwepheshe avelele, iSucceeder iwine ama-patents agunyaziwe angu-45, okuhlanganisa ama-patents okusungula angu-14, ama-patents emodeli yokusetshenziswa angu-16 kanye nama-patents okuklama angu-15. Le nkampani futhi inezitifiketi zokubhaliswa komkhiqizo wedivayisi yezokwelapha zesigaba sesi-2 ezingu-32, izitifiketi zokufaka zesigaba sesi-3, kanye nesitifiketi se-EU CE semikhiqizo engu-14, futhi iphumelele isitifiketi sesistimu yokuphatha ikhwalithi ye-ISO 13485 ukuqinisekisa ubuhle nokuzinza kwekhwalithi yomkhiqizo.

I-Succeeder ayiyona nje ibhizinisi elibalulekile le-Beijing Biomedicine Industry Leapfrog Development Project (G20), kodwa futhi yafika ngempumelelo kwi-Science and Technology Innovation Board ngo-2020, yafinyelela intuthuko eqhubekayo yenkampani. Njengamanje, inkampani yakhe inethiwekhi yokuthengisa kazwelonke ehlanganisa amakhulu ama-ejenti namahhovisi. Imikhiqizo yayo ithengiswa kahle ezingxenyeni eziningi zezwe. Iphinde yandise ngenkuthalo izimakethe zaphesheya kwezilwandle futhi ithuthukisa njalo ukuncintisana kwayo kwamazwe ngamazwe.